Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Docetaxel for Recurrent Sarcoma
NCT00073983Phase 2Completed
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- Oct 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of gemcitabine and docetaxel in osteosarcoma (OS), Ewing sarcoma and chondrosarcoma (3 arms), sponsored by Sarcoma Alliance for Research through Collaboration. Primary endpoint: Objective Response Rate. Started Oct 2006; status: completed.
02
Drugs
gemcitabinedocetaxel
03
Conditions
osteosarcoma (OS)Ewing sarcomachondrosarcoma
Beyond the preview
Go deeper on NCT00073983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00073983.